Life Spine Announces First Cases Performed with Multiple Methods of In-situ Expansion

My Subscriptions

Payment Confirmation

Transaction Failed

Your transaction failed, please try again or contact site support.

Life Spine announced today the first cases performed with multiple methods of in-situ expansion.

Dr. Thomas Scully of Tucson, AZ highlights, “Surgical intervention for the degenerative spine is a multi-dimensional challenge and by utilizing two methods of expansion, Life Spine allowed for me to cater to my patient’s unique pathologies. At one level, my goal was to provide the patient with restoration of significant disc height and sagittal alignment, while minimizing the need for excessive boney decompression and multiple passes by important neural structures. After reviewing intra-operative images this was accomplished with Life Spine’s PROLIFT® Lordotic system.” “Adjacent level pathology and patient bone quality dictated increased endplate coverage for stability and the ability to post-pack graft material to increase the chance of fusion, so TiBOW™ was the best choice,” concluded Dr. Scully.

ProLift Expandable PLIF/TLIF Spacer System and TiBOW Expandable TLIF Spacer System highlight Life Spine’s Micro Invasive Expandable portfolio. ProLift and TiBOW feature OSSEO-LOC Surface Treatment Technology, which is a proprietary surface treatment that creates a unique osteophylic surface architecture for potential bone on-growth1.

Vice President of Marketing for Life Spine Mariusz Knap added, “It is very exciting to be part of an organization that is able to provide physicians with innovative surgical solutions to accommodate patient’s distinct and challenging pathologies, especially where bone quality and disc access can be compromised. Each patient is unique and their treatment should be as well.”



Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.